UK clinical research could be ‘diminished’

The Household of Lords’ committee wrote to​ the Minister of State for Health and Social Treatment, Steve Barclay, with the conclusions it drew from its inquiry, which provided a variety of locations for ‘urgent action’.

The letter put into context that inspite of the UK’s ‘current economic situation’ and the ‘significant NHS backlog’, the net advantage of clinical exploration can mitigate workforce worries and enhance patient outcomes. However, the inquiry experienced observed that the scientific research ecosystem in the NHS is on a ‘dangerous precipice’ and with out action, the nation would reduce out on these types of benefits.

Chair of the Science and Know-how Committee, Julia King, reported: “Through the course of our inquiry we read alarming reports about the declining point out of clinical analysis in the NHS. ​

“There is a ‘leaky pipeline’ for marketing consultant medical lecturers who usually travel professional medical breakthroughs into frontline client care. If problems in shell out and pension inequality are not tackled, we are in risk of permanently eroding the medical research workforce and it is patients who will experience.​”

Further, King noted her problems that if measures are not taken by the Uk governing administration then the country’s scientific research capacity could be ‘permanently diminished’.

As a response to this predicament, the inquiry advised several potential tips, which bundled improved pay back to tackle inequalities that disincentivise clinical academia as a profession pathway, and to get rid of steps that inspire early retirement for NHS consultants.

FDA Passes New Cannabis Guidance for Clinical Research | Beveridge & Diamond PC

Critical Takeaways

  • What Happened: The Food items and Drug Administration (Food and drug administration) finalized a 2020 draft guidance detailing the agency’s suggestions for scientific analysis for building hashish and cannabis-derived human medication.
  • Who’s Impacted: Individuals associated in the clinical study of hashish can rely on this Food and drug administration guidance for suggested sources of cannabis for medical analysis and sources for facts on high-quality and control status issues. The steerage also suggests strategies for researchers to work out the THC dissimilarities concerning “hemp” and “cannabis.” The guidance can help tell stakeholders, lawmakers, and other folks in the hashish field by addressing particular issues elevated about drugs made up of cannabis and crucial Fda regulatory principles.

History

On January 24, 2023, the Food and drug administration announced new assistance entitled “Cannabis and Hashish-Derived Compounds: Top quality Criteria for Clinical Investigation.” The non-binding guidance discusses a few critical cannabis-associated subjects:

  • Sourcing cannabis for medical analysis
  • How to estimate percent delta-9 tetrahydrocannabinol (THC) all through the study cycle and,
  • Normal high quality considerations for creating human medications that contain hashish and cannabis-derived compounds.

Typically, to be viewed as “hemp,” a merchandise have to incorporate much less than .3 p.c delta-9 THC by dry bodyweight. Anything at all earlier mentioned .3 per cent delta-9 THC is regarded as hashish (or marijuana), a Plan I controlled substance. Human medications that incorporate hemp, hashish, and hashish-derived compounds are commonly subject to the exact same authorities and demands, together with excellent expectations, as Fda-regulated drug solutions that contains any other material.

The target of FDA’s hottest steering is to assist clinical exploration for the growth of hashish and cannabis-derived human prescription drugs. The direction does not handle the progress of thoroughly artificial variations of substances that take place in cannabis and does not deal with other Food and drug administration-regulated items.

Sourcing of Cannabis

The National Institute on Drug Abuse (NIDA) Drug Offer Plan was the only legal resource for scientists to purchase cannabis for many many years. The NIDA Drug Supply Application continues to be a resource of cannabis in excess of the .3 percent delta-9 THC threshold for clinical study. In 2020, the Drug Enforcement Company (DEA) adopted new procedures to permit the registration of new companies to plant, increase, cultivate, or harvest cannabis. There was confusion, even so, over no matter whether medical studies could use these new producers. This guidance intends to make clear that confusion and presents that:

  • For hashish in excess of the .3 {bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} delta-9 THC threshold and not part of an investigational new drug (IND) software – the NIDA Drug Provide Program and other sources authorized by DEA to supply Routine I cannabis resources for research can be made use of.
  • For any cannabis resources (earlier mentioned or beneath the .3 per cent threshold) as part of an IND software- other resources can be utilised matter to the approval of the software.

When the sourcing of hashish for medical analysis has been a apparent location of problem for individuals associated in the scientific research of hashish, the Food and drug administration also presented direction on additional nuanced problems that this sector faces.

Calculation of THC

Farmers and researchers have extended been involved about the calculation of THC, provided the unpredictable nature of the plant. Uncontrollable environmental factors as properly as extraction and manufacturing processes can influence the THC concentration and press lawful hemp into a managed substance. The steering endorses that experts calculate the THC material in their proposed hashish or hashish-derived investigational drug merchandise early in the enhancement procedure to decide their product’s probable abuse legal responsibility and command standing. The direction also discusses the very best calculation approaches all over the lifecycle of medical scientific studies.

Common High-quality Things to consider

As section of an IND for any drug, scientists are envisioned to display that they can continually manufacture a quality product or service. In each stage of clinical investigation, they must post enough details to show the drug’s identity, excellent, purity, and potency. The direction includes added concepts and tips that are specially related for acquiring prescription drugs that consist of cannabis and cannabis-derived compounds:

  • Hashish and cannabis-derived compounds are held to the same regulatory benchmarks as any other botanical uncooked content, botanical drug compound, or botanical drug product. This incorporates making sure batch-to-batch consistency, conducting microbiological exams and sterility assessments, and screening for raw components (between other unique necessities on p. 6 of the guidance).

  • Top quality assessments, particular to dosage type, should be done.
  • Impurities for obviously taking place compounds should be managed.
  • Researchers ought to not count on posted literature in area of details from a total toxicology system, as the certain botanical drug product below evaluate might differ from that of the released examine.
  • Evaluate the metabolic profile of big cannabinoids in human beings early for security.

Impacts

This Fda guidance allows presents clarity to the cannabis marketplace on hashish and hashish-derived drug progress in the wake of Congress passing the Healthcare Marijuana and Cannabidiol Analysis Expansion Act. Stakeholders have been eagerly awaiting updates from the Fda and other federal businesses with regards to the sale and promoting of cannabis-derived merchandise as effectively as a scientific assessment of cannabis to aid reevaluate the substance’s plan under the Controlled Substances Act. As a high precedence of the Biden Administration, we will most likely see numerous important regulatory updates for cannabis in 2023.

Businesses can submit on the web or published comments on this steerage at any time. The tips in this steering are not required or binding – researchers may possibly use an different strategy as extensive as it satisfies the necessities of the relevant statutes and polices.

[View source.]

McLaughlin Research Institute plans to establish a clinical research center

Wonderful FALLS — The McLaughlin Analysis Institute for Biomedical Sciences in Good Falls has served a major position in biomedical analysis in Montana for almost 70 decades.

Even though a great deal of their research has concentrated on working with mouse versions as a way to dissect the genetic basis of susceptibility to neurodegenerative diseases, they are on the path in the direction of a a lot more substantial goal, in the hopes that it will provide all types of benefits to the Treasure Condition. That purpose is creating 1 of the nation’s very first rural medical exploration facilities, which will be aimed at expanding clinical investigation in neurodegenerative conditions.

McLaughlin Study Institute Assistant Professor, Tiffany Hensley-McBain mentioned, “There are hundreds of scientific trials enrolling in Alzheimer’s disease correct now, and zero of them are recruiting in Montana. In point, usually, only eight studies on Alzheimer’s disorder have ever enrolled a Montanan.”

McLaughlin Investigate Institute claims the want for medical research growth in the state of Montana has grow to be much more important than at any time. They noted that Montana has regularly rated in the bottom 10{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} when it comes to participation and illustration in medical research nationwide.

They also mentioned that Montana has the sixth oldest population ratio in the nation. A little above 19 percent of our overall inhabitants is around the age of 65.

McLaughlin Investigate Institute says owing to the threat of neurodegenerative ailments growing with age, endorsing the enlargement of science and medicine by way of medical research that targets improvements in prognosis, cure, and avoidance of neurodegenerative diseases is a priority worry.

Clinical Exploration Coordinator, Rebecca Brown stated, “Scientific trials are at the coronary heart of all health-related developments. They are a system by which folks have obtain to the newest and ideal therapy. They also have the opportunity to deliver a whole lot of expertise to the neighborhood, and if we can carry in some clinical investigation on dementia and Alzheimer’s condition, I actually imagine that we can deliver a terrific profit to our state.

In an energy to raise the inclusion and expansion of medical investigation in Montana, McLaughlin Investigation Institute has introduced a registry of possible members for clinical investigation. This registry is open up to any older people of any age or prognosis. The function is to get a checklist of likely individuals for long term investigate research. The registry is referred to as “HERO” (Assisting Grow Investigation Alternatives).

How does the HERO Registry operate:

  • Your get hold of information is securely saved in a HIPAA – compliant database.
  • Minimum details is gathered.
  • Persons may perhaps be contacted if qualified for a examine, and there is no obligation to take part.
  • Any individual of any age and wellbeing position is encouraged to register 

To understand extra, speak to McLaughlin Exploration Institute for Biomedical Science at 406-452-6208, or by clicking in this article.


TRENDING

Adhere to KRTV


How Can Clinical Research Better Navigate Healthcare Deserts

By Mackenzie Ward and Jordyn Dinwiddie, Halloran Consulting Group

How Can Clinical Research Better Navigate Healthcare Deserts

Ample access to an array of healthcare solutions is integral to keeping and improving upon human wellbeing. All factors of health care engage in an vital role in a community’s properly-getting thanks to the multifaceted and dynamic mother nature of overall health. Despite this, large swaths of the U.S. remain healthcare deserts, exactly where accessibility to solutions this sort of as pharmacies, key care providers, hospitals, healthcare facility beds, trauma centers, and low-charge wellbeing facilities is severely confined.

In 2021, GoodRx documented that more than 80{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of counties across the U.S. lack sufficient health care infrastructure in some form or type. In addition, they believed that 121 million persons, accounting for above 37{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the U.S. populace, dwell in a healthcare desert (see the interactive map below).1 These people experience poorer wellbeing outcomes as a end result of the obvious absence of equitable health care entry.

Who Is Influenced By Health care Deserts?

The large greater part of healthcare deserts in the U.S. are in rural communities. Populations in rural places are likely to expertise increased trouble in accessing sufficient health care services because of to geographical barriers. Inhabitants of rural communities normally should vacation far larger distances to arrive at healthcare facilities (42{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of people have noted that transportation is a barrier to collaborating in medical trials), as most major clinical establishments reside in urban parts. This qualified prospects to poorer wellbeing outcomes in men and women in rural communities.

In the circumstance of cancer, “rural citizens are fewer probably to get cancer, but they are about 10{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} much more likely to die of the ailment than urban inhabitants.”2 This surprising statistic reveals the deep wellbeing disparities between rural and urban communities that are reflected across illnesses and ailments.

Healthcare Deserts Add To Underrepresentation In Scientific Investigate

The lack of entry to health care solutions additional harms rural communities by limiting entry to scientific analysis. There is presently an uneven distribution of trial web sites relative to the population with most important heath and exploration institutions clustered in city parts. As a result, the burdens associated with medical trial participation slide disproportionately on those people in rural locations. Transportation fees and all round time dedication are vastly larger and, frequently, rural communities are decrease revenue, have larger prices of uninsurance, and have reduced internet accessibility, as a result compounding barriers.

On top of that, persons in rural communities tend to be a lot less aware of accessible scientific demo alternatives. The bulk of advertising and marketing and recruiting for medical trials are performed in the urban spots wherever clinical sites are typically located, making it less complicated for individuals in city environments to learn about ongoing reports. This deficiency of exposure also feeds better distrust and concern in scientific analysis among the rural communities, driving folks away from any wish to participate.3

Whilst these barriers are hard to get over, it is significant that continued endeavours are made to involve rural populations in clinical investigate. Ideally, medical trials would be dispersed in an equitable way to manage scientific integrity, moral standards, and obtain to novel therapy possibilities. Although the present-day underrepresentation of rural communities fuels present well being disparities, recognition all over this difficulty is rising and extra clinical demo sponsors are getting the techniques to make significant variations to carry out clinical trials in a way that is a lot more agent of the whole population and can help facilitate trust in investigation and clinical establishments.

The Vital Roles Of Engineering And Community Outreach

Conducting scientific trials is challenging even in great options. Adding the complexity of healthcare deserts and the populations that reside in them offers an even better problem. Fortunately, numerous hospitals, providers, and businesses are turning out to be progressively knowledgeable of the challenge and are working to develop procedures to conquer some of the obstacles to efficiently carry out scientific studies in rural locations.

Technological innovations have built it attainable to perform research visits remotely, correctly lowering barriers regarding geographical length and transportation. Researchers can also leverage technology and shared details to use a number of satellite centers to conduct research visits in extra remote areas, somewhat than relying on city facilities. Decentralized medical trials are attaining popularity as an different to far more conventional clinical trials. Bringing medical trials instantly to people not only boosts accessibility for those in rural communities but has also improved affected individual usefulness and working experience. Some providers are selecting hybrid medical trials to achieve a broader population pool while also acknowledging the limits linked with specialized procedures and assessments.

Yet another step that is remaining taken to achieve rural populations is amplified neighborhood outreach. Educating people today on clinical demo selections and talking straight with underrepresented communities raises awareness and increases have confidence in between those who may not have experienced the exact same exposure. Just about every little move goes a extended way in creating a lot more possibilities for those dwelling in rural regions.

What Are Some Recent Market Efforts To Deal with It?

Other marketplace innovators are using their digital assets. CVS Overall health has crafted a decentralized product to produce medical trials utilizing their digital HealthHub that will allow for at-property companies.4 They identified that up to 30{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of those who enroll in medical trials end up dropping out, for good reasons which include inconvenient trial area.5 Decentralized clinical trials use technological know-how to converse with review individuals and obtain info. In some cases, the participant can use their personal cell cell phone to response queries or satisfy almost with the analyze employees. This lessens the number of in-human being visits and vacation, allowing for much more geographically numerous affected person pools.

The Dartmouth-Hitchcock Professional medical Heart is applying a multi-million greenback grant to grow their scientific trial web-sites to scaled-down stores in Maine and New Hampshire. This will allow for remedy access outside the house of large metropolitan areas. As rural clients are likely to have better rates of cardiovascular illness, the greater provision of treatment in these places has the probable to provide treatment method to individuals in want.

The College of North Carolina’s TraCS Inclusive Science Program is serving to to additional guidance scientific investigate in rural parts by the start of their Rural Health and fitness Research Toolkit. It is free of charge to down load and allows to establish protocols and recruitment and retention approaches, as very well as guidance to help interact rural communities in the study method.

A different illustration is the Oregon Local community Well being Details Community (OCHIN), which was established in 2000. They made a nonprofit that started off as a venture to increase healthcare access to all, irrespective of area or race. They have primarily focused on connecting men and women with primary treatment sources. They also give assistance with regulatory compliance and data on how to conduct pragmatic medical trials that will not increase the burden on currently stressed rural health care centers.4

The Ohio Condition College Detailed Cancer Center’s (OSUCCC) Centre for Cancer Health Fairness (CCHE) has formulated an outreach method to get in touch with individuals in rural pieces of the state. They collaborated with the OSUCCC cell mammography office to get mammography services to where by high-hazard women live, relatively than ready for these gals to arrive to them. The plan went to 9 counties that had no medical center at all. From 2015 to 2019, the software screened about 3,000 ladies and detected cancer in 32.6

Conclusion

Enough accessibility to healthcare providers is integral to maintaining and strengthening human overall health and yet, there are considerable pockets of the U.S. that remain health care deserts. But as technologies proceeds to offer you modern strategies to clinical study to convey health care choices to communities in need to have, we anticipate necessary enhancements to appear that bridge the health care gap and fosters believe in in clinical exploration.

References:

    &#13

  1. https://property.ctfassets.internet/4f3rgqwzdznj/1XSl43l40KXMQiJUtl0iIq/advert0070advertisement4534f9b5776bc2c410
    &#13
    91c321/GoodRx_Healthcare_Deserts_White_Paper.pdf
  2. &#13

  3. https://healthcare.utah.edu/huntsmancancerinstitute/news/2022/07/bringing-cancer-scientific-trials-to-rural-communities.php
  4. &#13

  5. https://pubmed.ncbi.nlm.nih.gov/24310703/
  6. &#13

  7. https://dcri.org/wp-information/uploads/2021/11/Addressing-Clinical-Demo-Deserts-Govt-Summary.pdf
  8. &#13

  9. https://www.cvshealth.com/information/medical-demo-providers/cvs-well being-introduces-clinical-trial-companies.html
  10. &#13

  11. https://ascopubs.org/doi/full/10.1200/OP.20.00174
  12. &#13

About The Authors

Mackenzie Ward is a advisor at Halloran Consulting Team. Before becoming a member of Halloran, she labored in the CRO place. She has a individual-focused viewpoint and is passionate about bringing procedure choices to underserved populations.

Jordyn Dinwiddie is a advisor at Halloran Consulting Team. Prior to joining Halloran, she labored for the New Mexico Division of Wellness coordinating the digital delivery of notifiable circumstances from hospitals and laboratories.

Amy Abernethy on fixing clinical trials

Clinical trials that are key to developing new treatments and medical devices have a lot of problems.

Researchers struggle to recruit participants, and the people who agree to take part are often not diverse enough. That can undermine the results if drugs or devices affect different people in different ways.

The Covid-19 pandemic, with the pressing need it created to develop treatments and vaccines, pushed clinical trial modernization efforts forward. Millions in venture funding have poured into the sector.

The 21st Century Cures Act of 2016 aimed to improve trials by reducing administrative burdens, and the FDA has made improving trials a priority over the past several years. Verily, a subsidiary of Google parent company Alphabet, hopes to be part of the solution.

Ben caught up with Amy Abernethy, the former No. 2 at the Food and Drug Administration and now president of Verily’s clinical research business. They discussed barriers to improving trials, the new Advanced Research Projects Agency for Health and more.

The interview is edited for length and clarity.

What is the state of clinical trials right now, and what needs to change?

We learned in Covid that our discovery engines were really working very, very fast. But clinical trials still are circa 1995. We also learned in Covid that we have the opportunity to shift how we do clinical trials, and that will speed up the process.

I see us moving towards clinical trials that include data that already exist in the system, like electronic health records and claims data. I see clinical trials leveraging new types of data, such as sensors in a watch to help you understand mobility. We’re going to see study designs that also leverage formalized clinical trials followed by longitudinal follow-up [tracking people over time]. There will be many new study designs.

What are the biggest obstacles to modernizing clinical trials? 

There are lots of obstacles to modernizing clinical trials, but most of them I see as surmountable.

If we’re going to leverage all available data, we’ve got to solve for the data quality mismatches that happen. Another critical thing to solve is we need to make clinical trials low-burden for participants. It shouldn’t get in the way of living. We need to make sure that clinical trials fit in the lives of people of all backgrounds so that clinical trials are representative of real populations.

Can you leverage data to better pair patients with trials? 

Recruitment is one of the hardest things in clinical trials. Oftentimes, about a third of the study budget goes to recruitment because it’s hard to find the right participant at the right moment.

You can’t just have one way of trying to solve it.

Yes, we think about the requirements of clinical trials and how to match that to the features of individual people who may be appropriate. But we also include digital marketing and campaigns to reach people and call centers and white-glove service to help that last mile of matching patients to trials.

What are the biggest obstacles to Verily’s success?

One of them is participant burden and a focus on patient centricity. I think about how digital and software and user experience works for us and other parts of our lives. We need to make sure that we bring the best of software design and fit that into workflow and life workflow in a way that’s completely patient-centric.

Another one is longitudinally. Clinical trials of the future are not going to be one week or two weeks long. We are going to follow people for long periods of time. We’re going to need to solve: How do people stay in trials for long periods of time?

President Joe Biden’s biomedical research agency, the Advanced Research Projects Agency for Health, is beginning to take shape with ambitious goals. What does it need to do to find new cures?

As they look to novel solutions in clinical trials and evidence generation, they’re going to need to think about leveraging data in new ways, including all available data, prospectively understanding and following products across time, making sure that we consent people to participate in efficient ways and that it’s fully transparent.

This is where we explore the ideas and innovators shaping health care. 

Do you think the Covid pandemic is over, or not? Send your thoughts to Carmen Paunand we may publish them in a future edition of Future Pulse.

Share any other thoughts, news, tips and feedback with Ben Leonard at [email protected], or Ruth Reader at [email protected].

We’re excited to announce that we have a new team member covering the future of health and how the pandemic has reshaped medicine, Erin Schumaker!

Erin was most recently Insider’s science editor, where her team covered space, climate, extreme weather and discoveries. Prior to that, she spent a decade as a health reporter at ABC News and HuffPost. Welcome her and send tips to [email protected] and follow her on Twitter @erinlschumaker.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

Today on ourPulse Checkpodcast, Katherine Ellen Foley talks with Alice Miranda Ollstein about the actions anti-abortion groups want the new GOP House majority to take.

Reducing air pollution could help combat dementia, according to a study recently published in the journal PNAS.

What’s the evidence? Researchers at the Emory University School of Public Health and Georgia Tech’s School of Earth and Atmospheric Sciences, among other institutions, explored whether there’s a link between air pollution and dementia by examining Medicare claims for 19 million people and estimates of air pollution levels in the areas where those people lived.

Sulfate and black carbon pollution showed the strongest association with dementia, followed by organic matter and ammonium. Nitrate and soil dust had relatively little linkage.

Why it matters: Nearly 6 million people in the U.S. live with dementia, which encompasses Alzheimer’s disease and other conditions that damage the brain, typically causing memory loss and the inability to think clearly.

That number is expected to rise to 14 million by 2060, according to the Alzheimer’s Association, with Hispanic and Black people most affected.

Public policy ideas: Reducing the concentration of fine particulate matter in the air, especially from traffic and sulfur-containing fossil fuel combustion, could have a significant public health impact, the researchers said.

More people are using smartphone apps they hope will improve their mental health.

But a new study in JAMA Network Open by researchers from Beth Israel Deaconess Medical Center in Boston says the apps have room for improvement.

The researchers found:

— Just 2 percent of the apps they studied were connected to electronic health records.

— Nearly half of the apps studied shared health data with third parties.

— It’s unclear whether the apps’ privacy policies are “accessible by most users.”

— Just half of the apps had an accessibility feature.

— Few apps were designed to treat serious illnesses.

The researchers also pointed to previous research showing that less than 5 percent of mental health apps have randomized clinical trials or other real-world evidence to back up the help they’re offering.

Among the apps the researchers studied, the most common aimed to treat substance abuse related to smoking or tobacco, stress and anxiety, and “nonserious mood disorders.”

“Overall, there is a lack of clinically supported mental health apps,” the researchers wrote. “The current app marketplaces lack diversity in their offerings and fail to implement potentially high-impact features.”

Clinical Research: A Review of Study Designs, Hypotheses, Errors, Sampling Types, Ethics, and Informed Consent

To conduct successful and credible research, scientists/researchers should understand the key elements of clinical research like neutrality (unbiased), reliability, validity, and generalizability. Moreover, results from clinical studies are applied in the real world to benefit human health. As a result, researchers must understand the various types of research designs [1]. Before choosing a research design, the researchers must work out the aims and objectives of the study, identify the study population, and address the ethical concerns associated with the clinical study. Another significant aspect of clinical studies is the research methodology and the statistical applications that are employed to process the data and draw conclusions. There are primarily two types of research designs: observational studies and experimental studies [2]. Observational studies do not involve any interventions and are therefore considered inferior to experimental designs. The experimental studies include the clinical trials that are carried out among a selected group of participants who are given a drug to assess its safety and efficacy in treating and managing the disease. However, in the absence of a study group, a single-case experimental design (SCED) was suggested as an alternative methodology that is equally reliable as a randomization study [3]. The single case study designs are called N-of-1 type clinical trials [4,5]. The N-of-1 study design is being increasingly applied in healthcare-related research. Experimental studies are complex and are generally performed by pharmaceutical industries as a part of research and development activities during the discovery of a therapeutic drug/device. Also, clinical trials are undertaken by individual researchers or a consortium. In a recent study, the researchers were cautioned about the consequences of a faulty research design [6]. It was noted that clinical studies on the effect of the gut microbiome and its relationship with the feed could potentially be influenced by the choice of the experimental design, controls, and comparison groups included in the study. Moreover, clinical studies can be affected by sampling errors and biases [7]. In the present review, we briefly discuss the types of clinical study designs, study hypotheses, sampling errors, and the ethical issues associated with clinical research.

Research design

A research design is a systematic elucidation of the whole research process that includes methods and techniques, starting from the planning of research, execution (data collection), analysis, and drawing a logical conclusion based on the results obtained. A research design is a framework developed by a research team to find an answer/solution to a problem. The research designs are of several types that include descriptive research, surveys, correlation type, experimental, review (systematic/literature), and meta-analysis. The choice of research design is determined by the type of research question that is opted for. Both the research design and the research question are interdependent. For every research question, a complementary/appropriate research design must have been chosen. The choice of research design influences the research credibility, reliability, and accuracy of the data collected. A well-defined research design would contain certain elements that include a specific purpose of the research, methods to be applied while collecting and analyzing the data, the research methodology used to interpret the collected data, research infrastructure, limitations, and most importantly, the time required to complete the research. The research design can broadly be categorized into two types: qualitative and quantitative designs. In a qualitative research method, the collected data are measured and evaluated using mathematical and statistical applications. Whereas in quantitative research, a larger sample size is selected, and the results derived from statistics can benefit society. The various types of research designs are shown in Figure 1 [8].

Types of research studies

There are various types of research study designs. The researcher who aims to take up the study determines the type of study design to choose among the available ones. The choice of study design depends on many factors that include but are not limited to the research question, the aim of the study, the available funds, manpower, and infrastructure, among others. The research study designs include systematic reviews, meta-analyses, randomized controlled trials, cross-sectional studies, case-control studies, cohort studies, case reports/studies, animal experiments, and other in vitro studies, as shown in Figure 2 [9].

Systematic Reviews

In these studies, the researcher makes an elaborate and up-to-date search of the available literature. By doing a systematic review of a selected topic, the researcher collects the data, analyses it, and critically evaluates it to evolve with impactful conclusions. Systematic reviews could equip healthcare professionals with more than adequate evidence with respect to the decisions to be taken during improved patient management that may include diagnosis, interventions, prognosis, and others [10]. A recent systematic research study evaluated the role of socioeconomic conditions on the knowledge of risk factors for stroke in the World Health Organization (WHO) European region. This study collected data from PubMed, Embase, Web of Science (WoS), and other sources and finally included 20 studies and 67,309 subjects. This study concluded that the high socioeconomic group had better knowledge of risk factors and warning signs of stroke and suggested improved public awareness programs to better address the issue [11].

Meta-Analysis

Meta-analysis is like a systematic review, but this type of research design uses quantitative tools that include statistical methods to draw conclusions. Such a research method is therefore considered both equal and superior to the original research studies. Both the systematic review and the meta-analyses follow a similar research process that includes the research question, preparation of a protocol, registration of the study, devising study methods using inclusion and exclusion criteria, an extensive literature survey, selection of studies, assessing the quality of the evidence, data collection, analysis, assessment of the evidence, and finally the interpretation/drawing the conclusions [12]. A recent research study, using a meta-analytical study design, evaluated the quality of life (QoL) among patients suffering from chronic pulmonary obstructive disease (COPD). This study used WoS to collect the studies, and STATA to analyze and interpret the data. The study concluded that non-therapeutic mental health and multidisciplinary approaches were used to improve QoL along with increased support from high-income countries to low and middle-income countries [13].

Cross-Sectional Studies

These studies undertake the observation of a select population group at a single point in time, wherein the subjects included in the studies are evaluated for exposure and outcome simultaneously. These are probably the most common types of studies undertaken by students pursuing postgraduation. A recent study evaluated the activities of thyroid hormones among the pre- and post-menopausal women attending a tertiary care teaching hospital. The results of this study demonstrated that there was no significant difference in the activities of thyroid hormones in the study groups [14].

Cohort Studies

Cohort studies use participant groups called cohorts, which are followed up for a certain period and assess the exposure to the outcome. They are used for epidemiological observations to improve public health. Although cohort studies are laborious, financially burdensome, and difficult to undertake as they require a large population group, such study designs are frequently used to conduct clinical studies and are only second to randomized control studies in terms of their significance [15]. Also, cohort studies can be undertaken both retrospectively and prospectively. A retrospective study assessed the effect of alcohol intake among human immunodeficiency virus (HIV)-infected persons under the national program of the United States of America (USA) for HIV care. This study, which included more than 30,000 HIV patients under the HIV care continuum program, revealed that excessive alcohol use among the participants affected HIV care, including treatment [16].

Case-Control Study

The case-control studies use a single point of observation among two population groups that are categorized based on the outcome. Those who had an outcome are termed as cases, and the ones who did not develop the disease are called control groups. This type of study design is easy to perform and is extensively undertaken as a part of medical research. Such studies are frequently used to assess the efficacy of vaccines among the population [17]. A previous study evaluated the activities of zinc among patients suffering from beta-thalassemia and compared it with the control group. This study concluded that the patients with beta-thalassemia are prone to hypozincaemia and had low concentrations of zinc as compared to the control group [18].

Case Studies

Such types of studies are especially important from the perspective of patient management. Although these studies are just observations of single or multiple cases, they may prove to be particularly important in the management of patients suffering from unusual diseases or patients presenting with unusual presentations of a common disease. Listeria is a bacterium that generally affects humans in the form of food poisoning and neonatal meningitis. Such an organism was reported to cause breast abscesses [19].

Randomized Control Trial

This is probably the most trusted research design that is frequently used to evaluate the efficacy of a novel pharmacological drug or a medical device. This type of study has a negligible bias, and the results obtained from such studies are considered accurate. The randomized controlled studies use two groups, wherein the treatment group receives the trial drug and the other group, called the placebo group, receives a blank drug that appears remarkably like the trial drug but without the pharmacological element. This can be a single-blind study (only the investigator knows who gets the trial drug and who is given a placebo) or a double-blind study (both the investigator and the study participant have no idea what is being given). A recent study (clinical trial registration number: NCT04308668) concluded that post-exposure prophylaxis with hydroxychloroquine does not protect against Coronavirus disease-19 (COVID-19) after a high and moderate risk exposure when the treatment was initiated within four days of potential exposure [20].

Factors that affect study designs

Among the different factors that affect a study’s design is the recruitment of study participants. It is not yet clear as to what is the optimal method to increase participant participation in clinical studies. A previous study had identified that the language barrier and the long study intervals could potentially hamper the recruitment of subjects for clinical trials [21]. It was noted that patient recruitment for a new drug trial is more difficult than for a novel diagnostic study [22].

Reproducibility is an important factor that affects a research design. The study designs must be developed in such a way that they are replicable by others. Only those studies that can be re-done by others to generate the same/similar results are considered credible [23]. Choosing an appropriate study design to answer a research question is probably the most important factor that could affect the research result [24]. This can be addressed by clearly understanding various study designs and their applications before selecting a more relevant design.

Retention is another significant aspect of the study design. It is hard to hold the participants of a study until it is completed. Loss of follow-up among the study participants will influence the study results and the credibility of the study. Other factors that considerably influence the research design are the availability of a source of funding, the necessary infrastructure, and the skills of the investigators and clinical trial personnel.

Synthesizing a research question or a hypothesis

A research question is at the core of research and is the point from which a clinical study is initiated. It should be well-thought-out, clear, and concise, with an arguable element that requires the conduction of well-designed research to answer it. A research question should generally be a topic of curiosity in the researcher’s mind, and he/she must be passionate enough about it to do all that is possible to answer it [25].

A research question must be generated/framed only after a preliminary literature search, choosing an appropriate topic, identifying the audience, self-questioning, and brainstorming for its clarity, feasibility, and reproducibility.

A recent study suggested a stepwise process to frame the research question. The research question is developed to address a phenomenon, describe a case, establish a relationship for comparison, and identify causality, among others. A better research question is one that describes the statement of the problem, points out the study area, puts focus on the study aspects, and guides data collection, analysis, and interpretation. The aspects of a good research question are shown in Figure 3 [26].

Research questions may be framed to prove the existence of a phenomenon, describe and classify a condition, elaborate the composition of a disease condition, evaluate the relationship between variables, describe and compare disease conditions, establish causality, and compare the variables resulting in causality. Some examples of the research questions include: (i) Does the coronavirus mutate when it jumps from one organism to another?; (ii) What is the therapeutic efficacy of vitamin C and dexamethasone among patients infected with COVID-19?; (iii) Is there any relationship between COPD and the complications of COVID-19?; (iv) Is Remdesivir alone or in combination with vitamin supplements improve the outcome of COVID-19?; (v) Are males more prone to complications from COVID-19 than females?

The research hypothesis is remarkably like a research question except for the fact that in a hypothesis the researcher assumes either positively or negatively about a causality, relation, correlation, and association. An example of a research hypothesis: overweight and obesity are risk factors for cardiovascular disease.

Types of errors in hypothesis testing

An assumption or a preliminary observation made by the researcher about the potential outcome of research that is being envisaged may be called a hypothesis. There are different types of hypotheses, including simple hypotheses, complex hypotheses, empirical hypotheses, statistical hypotheses, null hypotheses, and alternative hypotheses. However, the null hypothesis (H0) and the alternative hypothesis (HA) are commonly practiced. The H0 is where the researcher assumes that there is no relation/causality/effect, and the HA is when the researcher believes/assumes that there is a relationship/effect [27,28].

Hypothesis testing is affected by two types of errors that include the type I error (α) and the type II error (β). The type I error (α) occurs when the investigator contradicts the null hypothesis despite it being true, which is considered a false positive error. The type II error (β) happens when the researcher considers/accepts the null hypothesis despite it being false, which is termed a false negative error [28,29].

The reasons for errors in the hypothesis testing may be due to bias and other causes. Therefore, the researchers set the standards for studies to rule out errors. A 5{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} deviation (α=0.05; range: 0.01-0.10) in the case of a type I error and up to a 20{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} probability (β=0.20; range: 0.05-0.20) for type II errors are generally accepted [28,29]. The features of a reasonable hypothesis include simplicity and specificity, and the hypothesis is generally determined by the researcher before the initiation of the study and during the preparation of the study proposal/protocol [28,29].

The applications of hypothesis testing

A hypothesis is tested by assessing the samples, where appropriate statistics are applied to the collected data and an inference is drawn from it. It was noted that a hypothesis can be made based on the observations of physicians using anatomical characteristics and other physiological attributes [28,30]. The hypothesis may also be tested by employing proper statistical techniques. Hypothesis testing is carried out on the sample data to affirm the null hypothesis or otherwise.

An investigator needs to believe the null hypothesis or accept that the alternate hypothesis is true based on the data collected from the samples. Interestingly, most of the time, a study that is carried out has only a 50{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} chance of either the null hypothesis or the alternative hypothesis coming true [28,31].

Hypothesis testing is a step-by-step strategy that is initiated by the assumption and followed by the measures applied to interpret the results, analysis, and conclusion. The margin of error and the level of significance (95{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} free of type I error and 80{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} free of type II error) are initially fixed. This enables the chance for the study results to be reproduced by other researchers [32].

Ethics in health research

Ethical concerns are an important aspect of civilized societies. Moreover, ethics in medical research and practice assumes increased significance as most health-related research is undertaken to find a cure or discover a medical device/diagnostic tool that can either diagnose or cure the disease. Because such research involves human participants, and due to the fact that people approach doctors to find cures for their diseased condition, ethics, and ethical concerns take center stage in public health-related clinical/medical practice and research.

The local and international authorities like the Drugs Controller General of India (DCGI), and the Food and Drug Administration (FDA) make sure that health-related research is carried out following all ethical concerns and good clinical practice (GCP) guidelines. The ethics guidelines are prescribed by both national and international bodies like the Indian Council of Medical Research (ICMR) and the World Medical Association (WMA) Declaration of Helsinki guidelines for ethical principles for medical research involving human subjects [33].

Ethical conduct is more significant during clinical practice, medical education, and research. It is recommended that medical practitioners embark on self-regulation of the medical profession. Becoming proactive in terms of ethical practices will enhance the social image of a medical practitioner/researcher. Moreover, such behavior will allow people to comprehend that this profession is not for trade/money but for the benefit of the patients and the public at large. Administrations should promote ethical practitioners and penalize unethical practitioners and clinical research organizations. It is suggested that the medical curriculum should incorporate ethics as a module and ethics-related training must be delivered to all medical personnel. It should be noted that a tiny seed grows into an exceptionally gigantic tree if adequately watered and taken care of [33]. It is therefore inevitable to address the ethical concerns in medical education, research and practice to make more promising medical practitioners and acceptable medical educators and researchers as shown in Figure 4.

Sampling in health research

Sampling is the procedure of picking a precise number of individuals from a defined group to accomplish a research study. This sample is a true representative subset of individuals who potentially share the same characteristics as a large population, and the results of the research can be generalized [34,35]. Sampling is a prerogative because it is almost impossible to include all the individuals who want to partake in a research investigation. A sample identified from a representative population can be depicted in Figure 5.

Sampling methods are of different types and are broadly classified into probability sampling and non-probability sampling. In a probability sampling method, which is routinely employed in quantitative research, each individual in the representative population is provided with an equivalent likelihood of being included in the study [35]. Probability sampling can be separated into four types that include simple random sampling, systematic sampling, stratified sampling, and cluster sampling, as shown in Figure 6.

Simple Random Sample

In the simple random sampling method, every person in the representative population is given an equal chance of being selected. It may use a random number generator for selecting the study participants. To study the employees’ perceptions of government policies, a researcher initially assigns a number to each employee [35]. After this, the researcher randomly chooses the required number of samples. In this type of sampling method, each one has an equal chance of being selected.

Systematic Sample

In this sampling method, the researcher selects the study participants depending on a pre-defined order (1, 3, 5, 7, 9…), wherein the researcher assigns a serial number (1-100 (n)) to volunteers [35]. The researcher in this type of sample selects a number from 1 to 10 and later applies a systematic pattern to select the sample like 2, 12, 22, 32, etc.

Stratified Sample

The stratified sampling method is applied when the people from whom the sample must be taken have mixed features. In this type of sampling, the representative population is divided into clusters/strata based on attributes like age, sex, and other factors. Subsequently, a simple random or systematic sampling method is applied to select the samples from each group. Initially, different age groups, sexes, and other characters were selected as a group [35]. The investigator finds his/her sample from each group using simple or systematic random sampling methods.

Cluster Sample

This sampling method is used to create clusters of the representative population with mixed qualities. Because such groups have mixed features, each one can be regarded as a sample. Conversely, a sample can be developed by using simple random/systematic sampling approaches. The cluster sampling method is similar to stratified sampling but differs in the group characteristics, wherein each group has representatives of varied ages, different sexes, and other mixed characters [35]. Although each group appears as a sample, the researcher again applies a simple or systematic random sampling method to choose the sample.

Non-probability Sample

In this type of sampling method, the participants are chosen based on non-random criteria. In a non-probability sampling method, the volunteers do not have an identical opportunity to get selected. This method, although it appears to be reasonable and effortless to do, is plagued by selection bias. The non-probability sampling method is routinely used in experimental and qualitative research. It is suitable to perform a pilot study that is carried out to comprehend the qualities of a representative population [35]. The non-probability sampling is of four types, including convenience sampling, voluntary response sampling, purposive sampling, and snowball sampling, as shown in Figure 7.

Convenience Sample

In the convenience sampling method, there are no pre-defined criteria, and only those volunteers who are readily obtainable to the investigator are included. Despite it being an inexpensive method, the results yielded from studies that apply convenience sampling may not reflect the qualities of the population, and therefore, the results cannot be generalized [35]. The best example of this type of sampling is when the researcher invites people from his/her own work area (company, school, city, etc.).

Voluntary Response Sample

In the voluntary response sampling method, the participants volunteer to partake in the study. This sampling method is similar to convenience sampling and therefore leaves sufficient room for bias [35]. The researcher waits for the participants who volunteer in the study in a voluntary response sampling method.

Purposive Sample/Judgment Sample

In the purposive or judgemental sampling method, the investigator chooses the participants based on his/her judgment/discretion. In this type of sampling method, the attributes (opinions/experiences) of the precise population group can be achieved [35]. An example of such a sampling method is the handicapped group’s opinion on the facilities at an educational institute.

Snowball Sample

In the snowball sampling method, suitable study participants are found based on the recommendations and suggestions made by the participating subjects [36]. In this type, the individual/sample recruited by the investigator in turn invites/recruits other participants.

Significance of informed consent and confidentiality in health research

Informed consent is a document that confirms the fact that the study participants are recruited only after being thoroughly informed about the research process, risks, and benefits, along with other important details of the study like the time of research. The informed consent is generally drafted in the language known to the participants. The essential contents of informed consent include the aim of research in a way that is easily understood even by a layman. It must also brief the person as to what is expected from participation in the study. The informed consent contains information such as that the participant must be willing to share demographic characteristics, participate in the clinical and diagnostic procedures, and have the liberty to withdraw from the study at any time during the research. The informed consent must also have a statement that confirms the confidentiality of the participant and the protection of privacy of information and identity [37].

Health research is so complex that there may be several occasions when a researcher wants to re-visit a medical record to investigate a specific clinical condition, which also requires informed consent [38]. Awareness of biomedical research and the importance of human participation in research studies is a key element in the individual’s knowledge that may contribute to participation or otherwise in the research study [39]. In the era of information technology, the patient’s medical data are stored as electronic health records. Research that attempts to use such records is associated with ethical, legal, and social concerns [40,41]. Improved technological advances and the availability of medical devices to treat, diagnose, and prevent diseases have thrown a new challenge at healthcare professionals. Medical devices are used for interventions only after being sure of the potential benefit to the patients, and at any cost, they must never affect the health of the patient and only improve the outcome [42]. Even in such cases, the medical persons must ensure informed consent from the patients.